Public-Private Partnerships: Is the Time Ripe for Public-Good Investing?
This article was originally published in Start Up
Executive Summary
Public-private partnerships -- organizations formed with philanthropic funding to promote and/or manage R&D on orphan diseases -- say the time is right for public-good investing. Genomics is contributing to infectious disease drug discovery, but perhaps more important, the growth of an entrepreneurial biotech culture now makes it easier to move from basic research to product development, and to tap pharma's development expertise along the way.